Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 

Saved Queries

Sign in to use this feature.

Search Filter Reset All

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
Add Subjects Reset
Select Subjects

Journals

remove_circle_outline
remove_circle_outline
Add Journals Reset
Select Journals

Article Types

remove_circle_outline
remove_circle_outline
Add Article Types Reset
Select Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
Add Countries / Regions Reset
Select Countries / Regions
Update Search
share announcement

Search Results (3)

Search Parameters:
Keywords = aural hematoma

Order results
Result details
Results per page
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
12 pages, 2560 KiB  
Article
Platelet- Rich Plasma Treatment Supported by Ultrasound Detection of Septa in Recurrent Canine Aural Hematoma: A Case Series
by Paola Palagiano, Lisa Graziano, Walter Scarabello, Priscilla Berni, Valentina Andreoli and Stefano Grolli
Animals 2023, 13(15), 2456; https://doi.org/10.3390/ani13152456 - 29 Jul 2023
Cited by 4 | Viewed by 3089
Abstract
Aural hematoma is a common pathological condition in veterinary practice with a high incidence rate in dogs. Drainage, corticosteroid injections, and surgical approaches represent the common treatments in these clinical cases. However, surgery leaves visible signs and is usually correlated with recurrence, scars, [...] Read more.
Aural hematoma is a common pathological condition in veterinary practice with a high incidence rate in dogs. Drainage, corticosteroid injections, and surgical approaches represent the common treatments in these clinical cases. However, surgery leaves visible signs and is usually correlated with recurrence, scars, and deformation of the treated pinna. For this reason, more effective and less invasive methods have been proposed over the years. Platelet-Rich Plasma (PRP) is one of the most promising options due to its pro-regenerative properties and capability to modulate the inflammatory state. The present work reports 12 cases of canine aural hematoma treated with PRP. The PRP treatment was combined with an ultrasound evaluation of the pinna to detect and treat all involved septa. The results show that relatively large volumes (2 mL) of PRP associated with an ultrasound guide are safe and efficacious in the treatment of canine aural hematoma requiring a maximum of two infiltrations, both in acute and chronic conditions. All the patients recovered their normal ear thickness (compared with the controlateral one) without relapses, averaging 38.5 days from their first treatment (10–90 days; SD: 24.7). The key role of PRP combined with a tailored diagnosis process carried out by the veterinarian, which included using an ultrasound system and the proper bandage, suggests that this approach may represent a valid alternative to surgery and corticosteroids. Full article
(This article belongs to the Special Issue Regenerative Medicine in Animal Wound Healing and Musculoskeletal Disorders)
►▼ Show Figures

Graphical abstract

10 pages, 2375 KiB  
Review
A Review of Recent Developments in Veterinary Otology
by Richard Harvey
Vet. Sci. 2022, 9(4), 161; https://doi.org/10.3390/vetsci9040161 - 25 Mar 2022
Cited by 5 | Viewed by 10913
Abstract
The knowledge gap between practical research and its implementation in veterinary practice is becoming harder to bridge, as researchers now have a plethora of journals in which to publish. This paper summarizes recent research from the latest publications related to ear disease in [...] Read more.
The knowledge gap between practical research and its implementation in veterinary practice is becoming harder to bridge, as researchers now have a plethora of journals in which to publish. This paper summarizes recent research from the latest publications related to ear disease in dogs which have implications for veterinary practitioners. The topics reviewed include 16s rRNA new-generation sequencing, the use of oclacitinib in pinnal ulceration, the etiopathogenesis of aural hematoma, contamination of the middle ear during elective myringotomy and how to avoid it, and the use of carbon dioxide lasers in chronic obstructive otitis. Full article
(This article belongs to the Special Issue Advances in Small Animal Dermatology)
►▼ Show Figures

Figure 1

16 pages, 1641 KiB  
Article
Use of Autologous Leucocyte- and Platelet-Rich Plasma (L-PRP) in the Treatment of Aural Hematoma in Dogs
by Roberta Perego, Eva Spada, Elena Moneta, Luciana Baggiani and Daniela Proverbio
Vet. Sci. 2021, 8(9), 172; https://doi.org/10.3390/vetsci8090172 - 28 Aug 2021
Cited by 6 | Viewed by 5303
Abstract
Leukocyte- and platelet-rich plasma (L-PRP) can accelerate the healing process by providing increased concentrations of platelet-derived growth factors. The objective of this study was to evaluate the clinical effect of L-PRP in the treatment of canine aural hematomas associated with otitis externa. Twenty [...] Read more.
Leukocyte- and platelet-rich plasma (L-PRP) can accelerate the healing process by providing increased concentrations of platelet-derived growth factors. The objective of this study was to evaluate the clinical effect of L-PRP in the treatment of canine aural hematomas associated with otitis externa. Twenty mL of citrated whole blood was collected from each of the 17 dogs included and autologous L-PRP was produced. The aural hematoma was drained and 0.5–1 mL of L-PRP was injected. The dogs were examined weekly until 7 days after complete clinical healing. A final clinical follow-up was performed 6 weeks after the first treatment with L-PRP. If there was recurrence of the aural hematoma at the first follow-up, the treatment was repeated. In total, 2/17 cases were lost after the first follow-up. In 5/17 dogs, a short-term recurrence occurred. In 12/15 cases, complete clinical resolution was achieved with a single L-PRP application (Group A1) and in 3/15 with two treatments (Group A2). The mean time to complete clinical resolution was 16 ± 8.7 days (A1) and 23.3 ± 4 days (A2), respectively. No side effects were reported. The in situ administration of autologous L-PRP resulted in a complete resolution of the aural hematoma in all dogs that completed the clinical trial. Full article
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying article 1-50 on page 1 of 1.
Back to TopTop